Literature DB >> 980601

Differential effects of maternal heroin and methadone use on birthweight.

S R Kandall, S Albin, J Lowinson, B Berle, A I Eidelman, L M Gartner.   

Abstract

An analysis of birthweights of 337 neonates in relation to history of maternal narcotic usage was undertaken. Mean birthweight of infants born to mothers abusing heroin during the pregnancy was 2,490 gm, an effect primarily of intrauterine growth retardation. Low mean birthweight (2,615 gm) was also seen in infants born to mothers who had abused heroin only prior to this pregnancy, and mothers who had used both heroin and methadone during the pregnancy (2,535 gm). Infants born to mothers on methadone maintenance during the pregnancy had significantly higher mean birthweights (2.961 gm), but lower than the control group (3,176 gm). A highly significant relationship was observed between maternal methadone dosage in the first trimester and birthweight, i.e., the higher the dosage, the larger the infant. Heroin causes fetal growth retardation, an effect which may persist beyond the period of addiction. Methadone may promote fetal growth in a dose-related fashion after maternal use of heroin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 980601

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  27 in total

Review 1.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 2.  Detoxification considerations in the medical management of substance abuse in pregnancy.

Authors:  M H Allen
Journal:  Bull N Y Acad Med       Date:  1991 May-Jun

Review 3.  Drug addiction and pregnancy: policy crossroads.

Authors:  W Chavkin
Journal:  Am J Public Health       Date:  1990-04       Impact factor: 9.308

4.  Statement on drug use in pregnancy: an urgent problem for New York City. Committee on Public Health. The New York Academy of Medicine.

Authors: 
Journal:  Bull N Y Acad Med       Date:  1990 Mar-Apr

Review 5.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

6.  Neonatal behavior after drug dependent pregnancy.

Authors:  A L van Baar; P Fleury; S Soepatmi; C A Ultee; P J Wesselman
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

Review 7.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

Review 8.  Evaluation and management of opioid dependence in pregnancy.

Authors:  Eliza M Park; Samantha Meltzer-Brody; Joji Suzuki
Journal:  Psychosomatics       Date:  2012-08-14       Impact factor: 2.386

9.  Comparison of characteristics of opioid-using pregnant women in rural and urban settings.

Authors:  Sarah H Heil; Stacey C Sigmon; Hendree E Jones; Michael Wagner
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.